NAGE Niagen Bioscience Inc logo

NAGE Niagen Bioscience Inc

Healthcare
$3.90+0.00%OpenMarket Cap: $310.2M

As of 2026-05-26

Valuation

View Details

P/E (TTM)

20.59

PEG

0.20

P/B

3.55

P/S

2.24

EV/EBITDA

17.02

DCF Value

$-1.76

FCF Yield

1.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

64.3%

Operating Margin

8.5%

Net Margin

14.3%

ROE

25.4%

ROA

16.3%

ROIC

11.4%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$31.5M$6.3M$
Q4 null$33.8M$4.1M$
FY null$129.4M$17.4M$
Q3 null$34.0M$4.6M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$10.50

Target (Median)

$10.50

Target Range

$10.00 - $11.00

0 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell
HC Wainwright & Co.Buy
2026-05-11
Canaccord GenuityBuy
2026-05-05
Canaccord GenuityBuy
2026-03-31
Canaccord GenuityBuy
2025-11-05
HC Wainwright & Co.Buy
2025-08-11

Trading Activity

Insider Trades

View All
Fried Robert Ndirector, officer: Chief Executive Officer
SellMon Apr 27
Pamir Ozanofficer: Chief Financial Officer
SellTue Feb 24
Lopez Carlos Luisofficer: SVP, General Counsel
SellTue Feb 24
Fried Robert Ndirector, officer: Chief Executive Officer
SellTue Feb 24
Pamir Ozanofficer: Chief Financial Officer
BuyMon Nov 17

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

Beta

2.17

Niagen Bioscience Inc is a bioscience company dedicated to healthy aging. The Company leads research on nicotinamide adenine dinucleotide.

Peers